Digid is a Mainz-based healthtech startup founded in 2019. The company aims to enable real-time tracking and analysis of human #Biodata by combining Sensorics, Nanotech, and A.I. technologies. Digid was initiated by an interdisciplinary team of experienced specialists from the fields of diagnostics, pharma, nanotechnology, artificial intelligence, and digitalization. Their innovative solutions in digital diagnostics aim to revolutionize the analysis, real-time evaluation, and interpretation of multiple biomarkers and vital data. Digid recently secured an $8.00M Seed Round investment in January 2020. The investors behind this latest funding round are not disclosed. The startup operates within the biotechnology, health care, and medical devices industries, with its headquarters located in Germany.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Seed Round - digid | $8.00M | - | 15 Jan 2020 |
No recent news or press coverage available for digid GmbH.